Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05751980 · ClinicalTrials.gov registry record · NA

Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT05751980: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT05751980 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05751980, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

This study's overall goal is to enhance older adults' communication skills to access medication information and services to manage their medications safely and effectively. Med Wise Rx is an online 2-session program to improve communication skills for accessing medication information and services, leading to improved medication management. 160 adults age 65 years or older taking 4 or more medications will be on study for up to 9 months.

Primary Outcome

Specific questions included on survey tool will identify whether participant's report receiving a CMR, verifying (via protocol) Hometown Pharmacy CMRs reported.

Interventions

  • BEHAVIORAL Med Wise Rx

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2023-01-23
Est. Completion 2024-08-25
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05751980 record still lists

NCT05751980 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Med Wise Rx is the first listed.

NCT05751980 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05751980 about?

NCT05751980 is a clinical study titled "Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program". This study's overall goal is to enhance older adults' communication skills to access medication information and services to manage their medications safely and effectively. Med Wise Rx is an online 2-session program to improve communication skills for accessing medication information and services, l...

What is the current status of trial NCT05751980?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2023-01-23. Estimated completion is 2024-08-25.

What interventions are being tested in trial NCT05751980?

The interventions under investigation include: Med Wise Rx (BEHAVIORAL).

Who is sponsoring clinical trial NCT05751980?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05751980's enrollment target sits among peer trials

121 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05751980, the US trial registry maintained by the National Library of Medicine. NCT05751980 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.